Advertisement

Sleep-Related Drug Therapy in Special Conditions

Children
Published:September 07, 2022DOI:https://doi.org/10.1016/j.jsmc.2022.06.015

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dillon J.E.
        • Chervin R.D.
        Attention deficit, hyperactiv ity, and sleep disorders.
        in: Sheldon S.H. Ferber R. Kryger M.H. Principles and practice of pediatric sleep medicine. 2nd edition. Elsevier Saunders, New York2014: 111
        • Gringras P.
        Sleep and its disturbances in autism spectrum disorder.
        in: Sheldon S.H. Ferber R. Kryger M.H. Principles and practice of pediatric sleep medicine. 2nd edition. Elsevier Saunders, New York2014: 125
        • Chervin R.D.
        • Dillon J.E.
        • Bassetti C.
        • et al.
        Symptoms of sleep disorders, inattention, and hyperactivity in children.
        Sleep. 1997; 20: 1185-1192
        • Owens J.A.
        • Rosen C.L.
        • Mindell J.A.
        Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians.
        Pediatrics. 2003; 111: e628-e635
        • Sheldon S.H.
        • Spire J.P.
        • Levy H.B.
        Disorders of excessive somnolence.
        in: Sheldon S.H. Spire J.P. Levy H.B. Pediatric sleep medicine. WB Saunders, Phila- delphia1992: 91
        • Pelayo R.
        • Dubik M.
        Pediatric sleep pharmacology.
        Semin Pediatr Neurol. 2008; 15: 79-90
        • Troester M.M.
        • Pelayo R.
        Pediatric sleep pharma cology: a primer.
        Semin Pediatr Neurol. 2015; 22: 135-147
        • Schnoes C.J.
        • Kuhn B.R.
        • Workman E.F.
        • et al.
        Pediatric prescribing practices for clonidine and other phar macologic agents for children with sleep distur bance.
        Clin Pediatr (Phila). 2006; 45: 229-238
        • Stojanovski S.D.
        • Rasu R.S.
        • Balkrishnan R.
        • et al.
        Trends in medication prescribing for pediatric sleep difficulties in US outpatient settings.
        Sleep. 2007; 30: 1013-1017
        • American Academy of Sleep Medicine
        International classification of sleep disorders. 3rd edition. American Academy of Sleep Medicine, Darien (IL)2014
        • American Psychiatric Association
        Diagnostic and statistical manual of mental disorders.
        5th edition. American Psychiatric Publishing, Ar lington (VA)2013
        • Owens J.A.
        • Mindell J.A.
        Pediatric insomnia.
        Pediatr Clin North Am. 2011; 58: 555-569
        • Fossum I.N.
        • Nordnes L.T.
        • Storemark S.S.
        • et al.
        The association between use of electronic media in bed before going to sleep and insomnia symp- toms, daytime sleepiness, morningness, and chronotype.
        Behav Sleep Med. 2014; 12: 343-357
        • Shochat T.
        • Cohen-Zion M.
        • Tzischinsky O.
        Func tional consequences of inadequate sleep in ado- lescents: a systematic review.
        Sleep Med Rev. 2014; 18: 75-87
        • Jan J.E.
        • Bax M.C.
        • Owens J.A.
        • et al.
        Neurophysiology of circadian rhythm sleep disorders of children with neurodevelopmental disabilities.
        Eur J Paediatr Neurol. 2012; 16: 403-412
        • Honaker S.M.
        • Meltzer L.J.
        Bedtime problems and night wakings in young children: an update of the evidence.
        Paediatr Respir Rev. 2014; 15: 333-339
        • Sheldon S.H.
        • Spire J.P.
        • Levy H.B.
        Pediatric sleep medicine.
        WB Saunders, Philadelphia1992
        • Sivertsen B.
        • Harvey A.G.
        • Lundervold A.J.
        • et al.
        Sleep problems and depression in adolescence: results from a large population-based study of Nor wegian adolescents aged 16-18 years.
        Eur Child Adolesc Psychiatry. 2014; 23: 681-689
        • Miano S.
        • Parisi P.
        • Villa M.P.
        The sleep phenotypes of attention deficit disorder, the role of arousal during sleep and implications for treatment.
        Med Hypoth Eses. 2012; 79: 147-153
        • Owens J.A.
        Update in pediatric sleep medicine.
        Curr Opin Pulm Med. 2012; 17: 425-430
        • Mindell J.A.
        • Owens J.A.
        Sleep and medication. A clinical guide to pediatric sleep: diagnosis and management of sleep problems. sleep and medi- cation.
        Lippincott Williams & Wilkins, Philadelphia2003: 226-228
        • van Geijlswijk I.M.
        • van der Heijden K.B.
        • Egberts A.C.
        • et al.
        Dose finding of melatonin for chronic idio- pathic childhood sleep onset insomnia: an RCT.
        Psychopharmacology. 2010; 212: 379-391
        • Zee P.C.
        Shedding light on the effectiveness of melatonin for circadian rhythm sleep disorders.
        Sleep. 2010; 33: 1581-1582
        • Bruni O.
        • Alonso-Alconada D.
        • Besag F.
        • et al.
        Cur rent role of melatonin in pediatric neurology: clinical recommendations.
        Eur J Paediatr Neurol. 2015; 19: 122-133
        • Andersen I.M.
        • Kaczmarska J.
        • McGrew S.G.
        • et al.
        Melatonin for insomnia in children with autism spectrum disorders.
        J Child Neurol. 2008; 23: 482-485
        • Schwichtenberg A.J.
        • Malow B.A.
        Melatonin treat ment in children with developmental disabilities.
        Sleep Med Clin. 2015; 10: 181-187
        • Pelayo R.
        • Yuen K.
        Pediatric sleep pharmacology.
        Child Adolesc Psychiatr Clin N Am. 2012; 21: 861-883
        • Haydon 3rd, R.C.
        Are second-generation antihista mines appropriate for most children and adults?.
        Arch Otolaryngol Head Neck Surg. 2001; 127: 1510-1513
        • Richardson G.S.
        • Roehrs T.A.
        • Rosenthal L.
        • et al.
        Tolerance to daytime sedative effects of H1 antihis tamines.
        J Clin Psychopharmacol. 2002; 22: 511-515
        • Ingrassia A.
        • Turk J.
        The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders—a case series.
        Eur Child Adolesc Psychiatry. 2005; 14: 34-40
        • Wilens T.E.
        • Biederman J.
        • Spencer T.
        Clonidine for sleep disturbances associated with attention- deficit hyperactivity disorder.
        J Am Acad Child Adolesc Psychiatry. 1994; 33: 424-426
        • Newcorn J.H.
        • Stein M.A.
        • Childress A.C.
        • et al.
        Ran- domized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening admin- istration.
        J Am Acad Child Adolesc Psychiatry. 2013; 52: 921-930
        • Ashton H.
        Guidelines for the rational use of benzo diazepines. When and what to use.
        Drugs. 1994; 48: 25-40
        • Owens J.A.
        • Rosen C.L.
        • Mindell J.A.
        • et al.
        Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey.
        Sleep Med. 2010; 11: 692-700
        • Pershad J.
        • Palmisano P.
        • Nichols M.
        Chloral hy- drate: the good and the bad.
        Pediatr Emerg Care. 1999; 15: 432-435
        • Halal C.S.
        • Nunes M.L.
        Education in children’s sleep hygiene: which approaches are effective? A sys- tematic review.
        J Pediatr (Rio J. 2014; 90: 449-456
        • Rosen C.L.
        • Storfer-Isser A.
        • Taylor H.G.
        • et al.
        Increased behavioral morbidity in school-aged children with sleep-disordered breathing.
        Pediatrics. 2004; 114: 1640-1648
        • Marcus C.L.
        • Brooks L.J.
        • Draper K.A.
        • et al.
        Diagnosis and management of childhood obstructive sleep apnea syndrome.
        Pediatrics. 2012; 130: 576-584
        • Marcus C.L.
        Sleep-disordered breathing in chil dren.
        Am J Respir Crit Care Med. 2001; 164: 16-30
        • Brouillette R.T.
        • Manoukian J.J.
        • Ducharme F.M.
        • et al.
        Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea.
        J Pediatr. 2001; 138: 838-844
        • Chan C.C.
        • Au C.T.
        • Lam H.S.
        • et al.
        Intranasal cortico steroids for mild childhood obstructive sleep apnea-a randomized, placebo-controlled study.
        Sleep Med. 2015; 16: 358-363
        • Kheirandish-Gozal L.
        • Bandla H.P.
        • Gozal D.
        Montelu- kast for children with obstructive sleep apnea: results of a double-blind, randomized, placebo- controlled trial.
        Ann Am Thorac Soc. 2016; 13: 1736-1741
        • Goldbart A.D.
        • Greenberg-Dotan S.
        • Tal A.
        Montelu- kast for children with obstructive sleep apnea: a double-blind, placebo-controlled study.
        Pediatrics. 2012; 130: e575-e580
        • Wang B.
        • Liang J.
        The effect of montelukast on mild persistent OSA after adenotonsillectomy in chil dren: a preliminary study.
        Otolaryngol Head Neck Surg. 2017; 156: 952-954
        • Yang D.Z.
        • Liang J.
        • Zhang F.
        • et al.
        Clinical effect of montelukast sodium combined with inhaled corti costeroids in the treatment of OSAS children.
        Med Icine (Baltimore). 2017; 96: e6628
        • Kheirandish L.
        • Goldbart A.D.
        • Gozal D.
        Intranasal steroids and oral leukotriene modifier therapy in re sidual sleep-disordered breathing after tonsillec tomy and adenoidectomy in children.
        Pediatrics. 2006; 117: e61-e66
        • Don D.M.
        • Goldstein N.A.
        • Crockett D.M.
        • et al.
        Antimi crobial therapy for children with adenotonsillar hy pertrophy and obstructive sleep apnea: a prospective randomized trial comparing azithromy- cin vs placebo.
        Otolaryngol Head Neck Surg. 2005; 133: 562-568
        • Zhang J.
        • Chen J.
        • Yin Y.
        • et al.
        Therapeutic effects of different drugs on obstructive sleep apnea/hypo- pnea syndrome in children.
        World J Pediatr. 2017; 13: 537-543
        • Hudgel D.W.
        • Thanakitcharu S.
        Pharmacologic treat ment of sleep-disordered breathing.
        Am J Respir Crit Care Med. 1998; 158: 691-699
        • Marcus C.L.
        • Carroll J.L.
        • Bamford O.
        • et al.
        Supple mental oxygen during sleep in children with sleep-disordered breathing.
        Am J Respir Crit Care Med. 1995; 152: 1297-1301
        • Aljadeff G.
        • Gozal D.
        • Bailey-Wahl S.L.
        • et al.
        Effects of overnight supplemental oxygen in obstructive sleep apnea in children.
        Am J Respir Crit Care Med. 1996; 153: 51-55
        • Petit D.
        • Touchette E.
        • Tremblay R.E.
        • et al.
        Dyssom- nias and parasomnias in early childhood.
        Pediatrics. 2007; 119: e1016-e1025
        • Bjorvatn B.
        • Gronli J.
        • Pallesen S.
        Prevalence of different parasomnias in the general population.
        Sleep Med. 2010; 11: 1031-1034
        • Ohayon M.M.
        • Mahowald M.W.
        • Dauvilliers Y.
        • et al.
        Prevalence and comorbidity of nocturnal wander ing in the U.S. adult general population.
        Neurology. 2012; 78: 1583-1589
        • Kotagal S.
        Parasomnias in childhood.
        Sleep Med Rev. 2009; 13: 157-168
        • Attarian H.
        • Zhu L.
        Treatment options for disorders of arousal: a case series.
        Int J Neurosci. 2013; 123: 3
        • Provini F.
        • Tinuper P.
        • Bisulli F.
        • et al.
        Arousal disor ders.
        Sleep Med. 2011; 12: S22-S26
        • Wills L.
        • Garcia J.
        Parasomnias: epidemiology and management.
        CNS Drugs. 2002; 16: 803-810
        • Frank N.C.
        • Spirito A.
        • Stark L.
        • et al.
        The use of scheduled awakenings to eliminate childhood sleepwalking.
        J Pediatr Psychol. 1997; 22: 345-353
        • Sadeh A.
        Cognitive behavioral treatment for child hood sleep disorders.
        Clin Psychol Rev. 2005; 25: L612-L628
        • Hauri P.J.
        • Silber M.H.
        • Boeve B.F.
        The treatment of parasomnias with hypnosis: a 5-year follow up study.
        J Clin Sleep Med. 2007; 3: 369-373
        • Peterson P.C.
        • Husain A.M.
        Pediatric narcolepsy.
        Brain Development. 2008; 30: 609-623
        • Serra L.
        • Montagna P.
        • Mignot E.
        • et al.
        Cataplexy fea tures in childhood narcolepsy.
        Mov Disord. 2008; 23: 858-865
        • Kotagal S.
        • Krahn L.E.
        • Slocumb N.
        A putative link between childhood narcolepsy and obesity.
        Sleep Med. 2004; 5: 147-150
        • Plazzi G.
        • Pizza F.
        • Palaia V.
        • et al.
        Complex move ment disorders at disease onset in childhood nar colepsy with cataplexy.
        Brain. 2011; 134: 3480-3492
        • Silber M.H.
        • Krahn L.E.
        • Olson E.J.
        • et al.
        The epidemi ology of narcolepsy in Olmsted County, Minnesota: a population-based study.
        Sleep. 2002; 25: 197-202
        • Longstreth Jr., W.T.
        • Koepsell T.D.
        • Ton T.G.
        • et al.
        The epidemiology of narcolepsy.
        Sleep. 2007; 30: 13-26
        • Nishino S.
        • Ripley B.
        • Overeem S.
        • et al.
        Hypocretin (orexin) deficiency in human narcolepsy.
        Lancet. 2000; 355: 39
        • Thannickal T.C.
        • Moore R.Y.
        • Nienhuis R.
        • et al.
        Reduced number of hypocretin neurons in human narcolepsy.
        Neuron. 2000; 27: 469
        • Arii J.
        • Kanbayashi T.
        • Tanabe Y.
        • et al.
        A hypersomnolent girl with decreased CSF hypo- cretin level after removal of a hypothalamic tumor.
        Neurology. 2001; 56: 1775-1776
        • Scammell T.E.
        • Nishino S.
        • Mignot E.
        • et al.
        Narco- lepsy and low CSF orexin (hypocretin) concentra- tion after a diencephalic stroke.
        Neurology. 2001; 56: 1751-1753
        • Malik S.
        • Boeve B.F.
        • Krahn L.E.
        • et al.
        Narcolepsy associated with other central nervous system disor ders.
        Neurology. 2001; 57: 539-541
        • Gledhill R.F.
        • Bartel P.R.
        • Yoshida Y.
        • et al.
        Narcolepsy caused by acute disseminated encephalomyelitis.
        Arch Neurol. 2004; 61: 758-760
        • Babiker M.O.
        • Prasad M.
        Narcolepsy in children: a diagnostic and management approach.
        Pediatr Neurol. 2015; 52: 557-565
        • Aran A.
        • Einen M.
        • Lin L.
        • et al.
        Clinical and therapeu tic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
        Sleep. 2010; 33: 1457-1464
        • Billiard M.
        • Bassetti C.
        • Dauvilliers Y.
        • et al.
        EFNS guidelines on management of narcolepsy.
        Eur J Neurol. 2006; 13: 1035-1048
        • Syed Y.Y.
        Pitolisant: first global approval.
        Drugs. 2016; 76: 1313-1318
        • Szakacs Z.
        • Dauvilliers Y.
        • Mikhaylov V.
        • et al.
        Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomized, double-blind, pla- cebo-controlled trial.
        Lancet Neurol. 2017; 16: 200-207
      1. Product information: dextroamphetamine sulfate oral tablets, dextroamphetamine sulfate oral tab- lets. Mallinckrodt, St Louis (MO)2007
      2. Product information: RITALIN oral tablets, methyl- phenidate hydrochloride oral tablets. Novartis, East Hanover (NJ)2007
      3. Available at: https://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4202B1 _07_FDA-Tab07.pdf. Accessed March 28, 2018.

        • Thorpy M.J.
        Modafinil/armodafinil in the treatment of narcolepsy.
        in: Goswami M. Thorpy M.J. Pandi- Perumal S.R. Narcolepsy. A clinical guide. Springer International Publishing, Switzerland2016: 331-339
        • Ivanenko A.
        • Tauman R.
        • Gozal D.
        Modafinil in the treatment of excessive daytime sleepiness in chil dren.
        Sleep Med. 2003; 4: 579-582
        • Harsh J.R.
        • Hayduk R.
        • Rosenberg R.
        • et al.
        The effi- cacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.
        Curr Med Res Opin. 2006; 22: 761-774
        • Dauvilliers Y.
        • Bassetti C.
        • Lammers G.J.
        • et al.
        Pitoli- sant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
        Lan- Cet Neurol. 2013; 12: 1068-1075
        • Cak H.T.
        • Haliloglu G.
        • Duzgun G.
        • et al.
        Success ful treatment of cataplexy in patients with Nie- mann Pick disease type C: use of tricyclic antidepressants.
        Eur J Paediatr Neurol. 2014; 18: 811-815
        • Morgenthaler T.I.
        • Kapur V.K.
        • Brown T.
        • et al.
        Stan dards of practice committee of the AASM. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.
        Sleep. 2007; 30: 1705-1711
        • Lopez R.
        • Dauvilliers Y.
        Pharmacotherapy options for cataplexy.
        Expert Opin Pharmacother. 2013; 14: 895-903
        • Lammers G.J.
        • Arends J.
        • Declerck A.C.
        • et al.
        Gam- mahydroxybutyrate and narcolepsy: a double- blind placebo-controlled study.
        Sleep. 1993; 16: 216-220
        • US Xyrem Multicenter Study Group
        Sodium oxy- bate demonstrates long-term efficacy for the treat ment of cataplexy in patients with narcolepsy.
        Sleep Med. 2004; 5: 119-123
        • Black J.
        • Houghton W.C.
        Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
        Sleep. 2006; 29: 939-946
        • Van Schie M.K.
        • Werth E.
        • Lammers G.J.
        • et al.
        Improved vigilance after sodium oxybate treatment in narcolepsy: a comparison between in-field and in laboratory measures.
        J Sleep Res. 2016; 25: 486-496
        • Mansukhani M.
        • Kotagal S.
        Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
        Sleep Med. 2012; 13: 606-610
        • Lecendreux M.
        • Poli F.
        • Oudiette D.
        • et al.
        Tolerance and efficacy of sodium oxybate in childhood narco- lepsy with cataplexy: a retrospective study.
        Sleep. 2012; 35: 709-711
        • Rogers A.E.
        • Aldrich M.S.
        • Lin X.
        A comparison of three different sleep schedules for reducing day- time sleepiness in narcolepsy.
        Sleep. 2001; 24: 385-391
        • Picchietti D.L.
        • Bruni O.
        • de Weerd A.
        • et al.
        Pediatric restless legs syndrome diagnostic criteria: an up- date by the International restless legs syndrome study group.
        Sleep Med. 2013; 14: 1253-1259
        • Allen R.P.
        • Picchietti D.L.
        • Garcia-Borreguero D.
        • et al.
        Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria-history, rationale, description, and signifi- cance.
        Sleep Med. 2014; 15: 860-873
        • Picchietti M.A.
        • Picchietti D.L.
        Restless legs syn- drome and periodic limb movement disorder in children and adolescents.
        Semin Pediatr Neurol. 2008; 15: 91-99
        • Picchietti D.L.
        • Rajendran R.R.
        • Wilson M.P.
        • et al.
        Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs.
        Sleep Med. 2009; 10: 925-931
        • Ohayon M.M.
        • O’Hara R.
        • Vitiello M.V.
        Epidemiology of restless legs syndrome: a synthesis of the litera ture.
        Sleep Med Rev. 2012; 16: 283-295
        • Picchietti D.
        • Allen R.P.
        • Walters A.S.
        • et al.
        Restless legs syndrome: prevalence and impact in children and adolescents-the Peds.
        REST Study Pediatr. 2007; 120: 253-266
        • Zhang J.
        • Lam S.P.
        • Li S.X.
        • et al.
        Restless legs symp toms in adolescents: epidemiology, heritability, and pubertal effects.
        J Psychosom Res. 2014; 76: 158-164
        • Allen R.P.
        Restless leg syndrome/Willis-Ekbom dis ease pathophysiology.
        Sleep Med Clin. 2015; 10: 207-214
        • Rye D.B.
        The molecular genetics of restless legs syndrome.
        Sleep Med Clin. 2015; 10: 227-233
        • Mindell J.A.
        • Emslie G.
        • Blumer J.
        • et al.
        Pharmaco- logic management of insomnia in children and ad- olescents: consensus statement.
        Pediatrics. 2006; 117: e1223-e1232
        • Picchietti D.L.
        Should oral iron be first-line therapy for pediatric restless legs syndrome and periodic limb movement disorder?.
        Sleep Med. 2017; 32: 220-221
        • Dye T.J.
        • Jain S.V.
        • Simakajornboon N.
        Outcomes of long-term iron supplementation in pediatric rest- less legs syndrome/periodic limb movement disor- der (RLS/PLMD).
        Sleep Med. 2017; 32: 213-219
        • Picchietti D.L.
        • Stevens H.E.
        Early manifestations of restless legs syndrome in childhood and adoles- cence.
        Sleep Med. 2008; 9: 770-781
        • Walters A.S.
        • Mandelbaum D.E.
        • Lewin D.S.
        Dopami nergic therapy in children with restless legs/peri- odic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group.
        Pediatr Neurol. 2000; 22: 182-186